Sleep-Disordered Breathing: Advances in Diagnosis and Treatment

CASE DISCUSSION

Sleep-Disordered Breathing: Advances in Diagnosis and Treatment

Presented from by Dr. S. K. Jindal

Case Description

Sleep-disordered breathing (SDB), including obstructive sleep apnea, is a common condition with significant health consequences if left untreated. Advances in diagnostic tools such as home sleep testing, wearable devices, and improved polysomnography have made evaluation more accessible and...

Case Summary

  • Sleep disorders are a significant health concern, encompassing a wide spectrum of conditions from chronic snoring to severe obstructive sleep apnea (OSA). OSA, characterized by frequent upper airway obstructions during sleep, is the most prevalent type. Diagnosing sleep disorders is often delayed due to a lack of awareness and difficulties in recognition.

Speaker Profile

Dr. S. K. Jindal

Dr. S. K. Jindal

Former Professor & Head, Department of Pulmonary Medicine at the PGI, Chandigarh
Dr Jindal was honored with the Outstanding Educator Award (2011) for scientific contributions by the American Thoracic Society. He has also received Honors from other International Bodies such as the American College of Chest Physicians, USA (Governor’s Community Service Award and End-of-life Commendation) and International Union Against TB & Lung Diseases, France (Best Scientific Contributions in Non-tuberculous Lung Diseases). He has also been awarded by many national agencies including the National Academy of Medical Sciences, Indian Council of Medical Research and Association of Physicians of India. The Indian Chest Society honored him with the prestigious Life-time Achievement Award in 2011. Dr Jindal in the past, has been the President of the Indian Chest Society and other National Associations including the Indian Association of Bronchology and Indian Association for Sarcoidosis and Granulomatous Lung Diseases. He is a Fellow of the National Academy of Medical Sciences, American College of Chest Physicians and of several other scientific and professional organizations. He has also served on the Scientific and Academic Committees of several national and international organizations. He has undertaken several investigational projects including large multi-centre studies sponsored by national and international agencies. He has also pioneered guidelines for management of different lung diseases, as well as published over 320 scientific papers and reviews

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.